Internal Medicine, Endocrinology, Diabetes, & Metabolism · Hyannis, MA
NPI
1003854365
Since 2006
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
1
Medicare group memberships
Hospitals
4
Hospital affiliations
1030 Falmouth Rd
Hyannis, MA, 02601
Phone (774) 470-5080
Groups this clinician bills Medicare through
Medicare paid, 2024
$87K
1,871 services
Medicare patients, 2024
438
Average age 76
Drug cost, 2024
$1.5M
3,420 prescriptions
Company payments, 2025
$1,311
From 23 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Mary W Crowell was code 99214 (office e&m - established), 509 times for 279 patients. In total Mary W Crowell billed 1,871 services in 17 codes, and Medicare paid $87K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-05-22.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 509 | 279 | $90.30 | $46K |
| 99213 Office E&M - Established | Office | 193 | 160 | $65.39 | $13K |
| 82962 Clinical Chemistry | Office | 118 | 86 | $3.18 | $376 |
| 83036 Blood Count | Office | 112 | 79 | $9.44 | $1,057 |
| 76536 Ultrasound - Nonspecific | Office | 86 | 83 | $81.04 | $6,970 |
| 95251 Test - Miscellaneous | Office | 81 | 48 | $27.18 | $2,202 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 75 | 70 | $12.92 | $969 |
| 99451 E&M - Miscellaneous | Office | 36 | 35 | $24.59 | $885 |
| 99443 Telephone Services | Office | 20 | 13 | $88.73 | $1,775 |
| 99442 Telephone Services | Office | 15 | 13 | $58.58 | $879 |
By year: 2022 $171K for 6,549 services; 2023 $153K for 4,998 services; 2024 $87K for 1,871 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 82962 Clinical Chemistry | 118 | 86 | $3.18 | $376 |
| 83036 Blood Count | 112 | 79 | $9.44 | $1,057 |
Medicare prescription drug claims, 2024
In 2024, the drug Mary W Crowell prescribed most often to Medicare patients was Levothyroxine Sodium, with 549 prescriptions and refills. In total Mary W Crowell wrote 3,420 Medicare prescriptions that cost $1.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 549 | 1,474 | 147 | $6,759 |
| Synthroid Levothyroxine Sodium | 237 | 677 | 67 | $26K |
| Trulicity Dulaglutide | 193 | 245 | 33 | $233K |
| Ozempic Semaglutide | 162 | 257 | 39 | $243K |
| Glimepiride Generic | 126 | 356 | 36 | $1,567 |
| Metformin Hcl Er Metformin Hcl | 120 | 354 | 36 | $1,562 |
| Mounjaro Tirzepatide | 117 | 139 | 17 | $140K |
| Metformin Hcl Generic | 110 | 310 | 28 | $1,101 |
| Tresiba Flextouch U-100 Insulin Degludec | 106 | 270 | 32 | $57K |
| Nano 2nd Gen Pen Needle Pen Needle, Diabetic | 102 | 280 | 35 | $12K |
| Jardiance Empagliflozin | 91 | 236 | 27 | $131K |
| Liothyronine Sodium Generic | 87 | 261 | 25 | $4,044 |
| Tirosint Levothyroxine Sodium | 79 | 120 | Under 11 | $16K |
| Tresiba Flextouch U-200 Insulin Degludec | 72 | 164 | 17 | $84K |
| Atorvastatin Calcium Generic | 66 | 172 | 20 | $635 |
Brand drugs: 1,676 claims; generic drugs: 1,489 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Mary W Crowell $1,311 ($1,311 in general payments such as food, travel and fees) from 23 companies. The largest payer was Amgen Inc. with $249.
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. AMGN | 11 | $249 |
| UCB, Inc. UCB.BR | 8 | $149 |
| Abbott Laboratories ABT | 4 | $111 |
| Xeris Pharmaceuticals, Inc. | 5 | $109 |
| Medtronic, Inc. MDT | 3 | $65.25 |
| GlaxoSmithKline, LLC. GSK | 3 | $60.17 |
| Vertex Pharmaceuticals Incorporated VRTX | 2 | $57.37 |
| AstraZeneca Pharmaceuticals LP AZN | 2 | $54.55 |
| Lilly USA, LLC LLY | 3 | $51.83 |
| Novo Nordisk Inc NVO | 2 | $49.03 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.